Roberto Nani
Impact in
- Hepatology top 2%
- Hepatocellular Carcinoma Treatment and Prognosis
- Liver Disease and Transplantation
- Liver physiology and pathology
-
- Cancer Mechanisms and Therapy
Papers in
-
- Renal cell carcinoma treatment 2
- Lung Cancer Treatments and Mutations 2
-
- Hepatocellular Carcinoma Treatment and Prognosis 6
- Co-authors
- Andrea Doriguzzi Breatta (1 shared paper)Rita Golfieri (1 shared paper)Emanuela Giampalma (1 shared paper)Alessandro Cucchetti (1 shared paper)Matteo Renzulli (1 shared paper)Irene Bargellini (1 shared paper)Franco Trevisani (1 shared paper)Roberto Cioni (1 shared paper)
- Journals
- British Journal of Cancer (1 paper)Future Oncology (1 paper)Integrative Cancer Therapies (1 paper)International Journal of Technology Management (1 paper)Kidney International (1 paper)
- Partner nations
- ItalyUnited StatesGermany
In The Last Decade
Roberto Nani
13 papers receiving 647 citations
Roberto Nani's Hit Papers
Peers
Comparison fields: 5 of 67
- Hepatology 505
- Pathology and Forensic Medicine 111
- Epidemiology 209
- Surgery 200
- Transplantation 12
Countries citing papers authored by Roberto Nani
This map shows the geographic impact of Roberto Nani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roberto Nani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roberto Nani more than expected).
Fields of papers citing papers by Roberto Nani
This network shows the impact of papers produced by Roberto Nani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roberto Nani. The network helps show where Roberto Nani may publish in the future.
Co-authors
The 25 scholars most cited alongside Roberto Nani, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Randomised controlled trial of doxorubicin-eluting beads vs conventional chemoembolisation for hepatocellular carcinoma Hit paper breakdown → | 2014 | 432 |
| 2 | 2019 | 37 | |
| 3 | 2010 | 34 | |
| 4 | 2007 | 30 | |
| 5 | 2020 | 29 | |
| 6 | 2001 | 25 | |
| 7 | 2017 | 23 | |
| 8 | 2017 | 14 | |
| 9 | 2023 | 10 | |
| 10 | 2002 | 9 | |
| 11 | 2011 | 6 | |
| 12 | 2018 | 4 | |
| 13 | 2021 | 3 | |
| 14 | 2025 | 0 | |
| 15 | 2018 | 0 | |
| 16 | 2011 | 0 | |
| 17 | 2017 | 0 | |
| 18 | TRIZ-Based Patent Investigation by Evaluating Inventiveness. | 2008 | 0 |
About Roberto Nani
Roberto Nani is a scholar working on Pulmonary and Respiratory Medicine, Hepatology, Epidemiology, Oncology and Surgery, having authored 18 papers that have together received 656 indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (6 papers), Colorectal Cancer Treatments and Studies (2 papers), Neuroblastoma Research and Treatments (2 papers), Liver Disease Diagnosis and Treatment (2 papers), Renal cell carcinoma treatment (2 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (2 papers), Pancreatic and Hepatic Oncology Research (2 papers) and Lung Cancer Treatments and Mutations (2 papers). The work is most often cited by research in Hepatology (505 citations), Pathology and Forensic Medicine (111 citations), Epidemiology (209 citations), Surgery (200 citations) and Transplantation (12 citations). Roberto Nani has collaborated with scholars based in Italy, United States and Germany. Frequent co-authors include Andrea Doriguzzi Breatta, Rita Golfieri, Emanuela Giampalma, Alessandro Cucchetti, Matteo Renzulli, Irene Bargellini, Franco Trevisani, Roberto Cioni, Daniele Gasparini and Carlo Bartolozzi. Their work appears in journals such as British Journal of Cancer, Future Oncology, Integrative Cancer Therapies, International Journal of Technology Management and Kidney International.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.